Showing results (101-110 of 170) with videos related to
Sort By:
Pageof 17
Analytical Chemistry|January 27, 2026
IsoPS-DIA: Dual Functionality of Absolute Targeted Quantification and Global Proteome ProfilingHsin-Ju Chan, Huan-Chi Chiu, Li-Yu Chen, et al.British Journal of Cancer|February 21, 2013
Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancerC-Y Lu, H-L Tsai, Y-H Uen, et al.Cancer Science|September 1, 2018
Ubiquitin-specific protease 3 overexpression promotes gastric carcinogenesis and is predictive of poor patient prognosisChia-Lang Fang, Chih-Chan Lin, Han-Kun Chen, et al.Cancer Medicine|May 24, 2018
Loss of cyclin-dependent kinase-like 2 predicts poor prognosis in gastric cancer, and its overexpression suppresses cells growth and invasionChia-Lang Fang, Yih-Huei Uen, Han-Kun Chen, et al.Surgery Today|March 24, 2006
Surgical anatomy of the recurrent laryngeal nerves and its clinical applications in chinese adultsYih-Huei Uen, Tien-Hua Chen, Jia-Fwu Shyu, et al.Annals of Surgery|November 29, 2007
Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resectionYih-Huei Uen, Shiu-Ru Lin, Deng-Chyang Wu, et al.Circulation Journal : Official Journal of the Japanese Circulation Society|December 27, 2007
Magnetic dispersion of the late repolarization in Brugada syndromeBoyoung Joung, Kiwoong Kim, Yong-Ho Lee, et al.Annals of Surgical Oncology|May 16, 2008
Persistent presence of postoperative circulating tumor cells is a poor prognostic factor for patients with stage I-III colorectal cancer after curative resectionYih-Huei Uen, Chien-Yu Lu, Hsiang-Lin Tsai, et al.World Journal of Gastroenterology|May 27, 2005
Molecular mechanisms of denbinobin-induced anti-tumorigenesis effect in colon cancer cellsKuo-Ching Yang, Yih-Huei Uen, Fat-Moon Suk, et al.Annals of Surgery|December 17, 2009
Activating KRAS mutations and overexpression of epidermal growth factor receptor as independent predictors in metastatic colorectal cancer patients treated with cetuximabLi-Chen Yen, Yih-Huei Uen, Deng-Chyang Wu, et al.Pageof 17